In addition to announcing a new corp comms model, the Arthur W. Page Society is having a spring conference in NYC that wraps up today. Yesterday, I sat in on the “CEO Spotlight,” which was placed on healthcare/pharmaceutical company Novartis.
Novartis faces a dilemma, according to CEO Joe Jimenez. “We’re ranked first as Fortune magazine’s most admired pharmaceutical company, but the whole industry suffers from a poor reputation,” he said. He bemoaned that “public trust of pharma even ranks below oil and tobacco.”